Niu H - Search Results

1

T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.

Yang M, Yu Q, Liu J, Fu W, Cao Y, Yu L, Shao S, Wang X, Niu H, Wang Y. Yang M, et al. Among authors: niu h. J Surg Oncol. 2015 Sep;112(4):430-5. doi: 10.1002/jso.24012. Epub 2015 Aug 11. J Surg Oncol. 2015. PMID: 26265374

2

Outcomes for a large series of radical cystectomies for bladder cancer.

Niu HT, Xu T, Zhang YB, Pang DQ, Zhang ZL, Wu S, Cheng B, Wang Y, Chang JW, Sun G. Niu HT, et al. Eur J Surg Oncol. 2008 Aug;34(8):911-915. doi: 10.1016/j.ejso.2008.01.010. Epub 2008 Feb 21. Eur J Surg Oncol. 2008. PMID: 18294806

3

Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China.

Niu HT, Shao SX, Zhang ZL, Wu S, Cheng B, Pang de Q, E YJ, Dong SG, Sun G, Chang JW. Niu HT, et al. Int Urol Nephrol. 2009;41(3):571-7. doi: 10.1007/s11255-008-9470-4. Epub 2008 Sep 23. Int Urol Nephrol. 2009. PMID: 18810651

4

Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium.

Niu HT, Zhang YB, Jiang HP, Cheng B, Sun G, Wang Y, E YJ, Pang de Q, Chang JW. Niu HT, et al. Urol Oncol. 2009 Jul-Aug;27(4):400-6. doi: 10.1016/j.urolonc.2008.07.007. Epub 2008 Sep 24. Urol Oncol. 2009. PMID: 18818109

5

Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.

Liu W, Cao Y, Fernández MI, Niu H, Xiu Y. Liu W, et al. Among authors: niu h. Int Urol Nephrol. 2011 Sep;43(3):721-7. doi: 10.1007/s11255-010-9866-9. Epub 2010 Nov 12. Int Urol Nephrol. 2011. PMID: 21072592

6

Clinical relevance of heparanase mRNA expression in bladder cancer and its usefulness as a detection marker in voided urine.

Zhao W, Wang XS, Niu HT, Wang LL, Han BM, Xia SJ. Zhao W, et al. Mol Med Rep. 2009 Mar-Apr;2(2):327-31. doi: 10.3892/mmr_00000104. Mol Med Rep. 2009. PMID: 21475833

7

Shotgun proteome expression profile of microdissected superficial transitional cell carcinoma and biomarker discovery from urine.

Niu HT, Li SJ, Xu T, Yu QC, Chang JW, Sun G. Niu HT, et al. Mol Med Rep. 2009 Sep-Oct;2(5):719-23. doi: 10.3892/mmr_00000162. Mol Med Rep. 2009. PMID: 21475891

8

Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.

Niu HT, Yang CM, Jiang G, Xu T, Cao YW, Zhao J, Wang XS. Niu HT, et al. J Cancer Res Clin Oncol. 2011 Aug;137(8):1273-82. doi: 10.1007/s00432-011-0995-z. Epub 2011 Jun 25. J Cancer Res Clin Oncol. 2011. PMID: 21706132

9

Stromal proteome expression profile and muscle-invasive bladder cancer research.

Niu H, Jiang H, Cheng B, Li X, Dong Q, Shao L, Liu S, Wang X. Niu H, et al. Cancer Cell Int. 2012 Aug 25;12(1):39. doi: 10.1186/1475-2867-12-39. Cancer Cell Int. 2012. PMID: 22920603 Free PMC article.

10

Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma.

Niu HT, Qi XJ, Liu YQ, Cao YW, Dong Q, Wang XS. Niu HT, et al. Genet Mol Res. 2013 Feb 28;12(4):4251-63. doi: 10.4238/2013.February.28.28. Genet Mol Res. 2013. PMID: 23479173 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,042 results

Search Page

Filters